Postdoctoral Research Fellow @MassGenBrigham @HarvardMed @Brain_Circuits | interested in psychosis, causality, neuroimaging, neuromodulation @andrewpines.bsky

Boston, MA
Joined January 2016
Andrew Pines retweeted
Deeply honored to be awarded a BD2 Discovery Award together with my incredible co-PIs Fernando Goes (@HopkinsMedicine) and Chris Ching (@KeckMedicineUSC ) for our project 'Retrosplenial "Switch Cells" in Bipolar Disorder". Huge thanks to @BD2Discoveries for their support + vision
BD² is awarding more than $13M to 3 new Discovery Research teams studying the biology of mood state switching in #BipolarDisorder. 🧠 Teams are led by Laramie Duncan, PhD, Susan Dymecki, MD, PhD, & Akira Sawa, MD, PhD. 🔗 bit.ly/4rrCblZ
5
3
24
1,400
Andrew Pines retweeted
A surprising cause of hallucinations. A pathognomonic sign is a finding that is so characteristic it essentially confirms a diagnosis. Lee and Pedregosa present a striking Images in Clinical Medicine case in the New England Journal of Medicine demonstrating a classic "dot-in-hole" sign of neurocysticercosis, where the bright dot represents the scolex, or head, of a tapeworm living within a brain cyst. Key points: - A previously healthy 52-year-old woman developed progressive headaches, visual hallucinations, language dysfunction, and likely seizures over several months. - Brain MRI revealed multiple cystic lesions throughout the cerebral hemispheres and cerebellum containing an eccentric bright nodule, the classic "dot-in-hole" sign that is considered pathognomonic for parenchymal neurocysticercosis. - Treatment with praziquantel, albendazole, glucocorticoids, and levetiracetam led to clinical improvement and shrinkage of the cysts within one month. My take: One of the greatest lessons in neurology is to keep an open mind. Not every person with cognitive changes, seizures, hallucinations, or abnormal imaging has a neurodegenerative disease. Geography, travel history, exposure risks, and careful interpretation of neuroimaging remain critical. This image is a wonderful reminder that pattern recognition still matters, even in the era of biomarkers and artificial intelligence. Here are 5 points that resonated w/ me: 1- Neurocysticercosis remains one of the most common causes of acquired epilepsy worldwide and should remain on the differential diagnosis when evaluating new-onset seizures and multiple brain lesions. 2- The "dot-in-hole" sign is one of the most recognizable imaging findings in neurology because it directly visualizes the scolex within a cyst, making the diagnosis highly specific. 3- Careful review of MRI often provides the answer before invasive testing is needed. 4- Appropriate antiparasitic therapy, combined w/ anti-inflammatory treatment and seizure management, can lead to substantial clinical improvement. 5- Every neurologist should remember that uncommon diseases are not rare when practicing in a global community. Careful history-taking, thoughtful imaging review, and broad clinical reasoning remain among our most powerful diagnostic tools. nejm.org/doi/full/10.1056/NE…
2
36
2
126
9,228
New in @AmJPsychiatry — personally I think this is my best paper so far. Highest statistical rigor, strongest causal inference (via a series of natural experiments), and multiple clinical applications. Thanks @KJBinSTL and team tagged below. psychiatryonline.org/doi/10.…
3
27
1
78
9,589
Andrew Pines retweeted
Exciting to see clear evidence of the clinical potential of resting-state fMRI! Also amazed that @foxmdphd was instrumental in developing resting-state fMRI as a tool to probe human brain networks in vivo, then translating it to the clinic. What an achievement!
8
35
4,666
Check out our latest work, out today in @molpsychiatry, led by Soyoung Lee. By the time we see brain atrophy on MRI, disease is often pretty far along - a problem now that antibody tx (and maybe TMS) work best early. nature.com/articles/s41380-0…
1
14
1
31
5,419
Andrew Pines retweeted
Is brain circuit targeted TMS better at treating depression than scalp targeted TMS? New paper by Joe Taylor @Brain_Circuits out today in @JAMAPsych says yes! Connectivity- vs Scalp-Based Targeting of Accelerated TMS for Depression jamanetwork.com/journals/jam…
2
24
2
73
10,161
We all thought this study would fail, for different reasons. Joe Taylor (1st author) thought it'd be a takedown of fMRI-guided TMS. @foxmdphd and I (co-senior authors) thought the effect would be too small to detect in just 40 patients. We were wrong. jamanetwork.com/journals/jam…
6
37
4
101
14,406
Andrew Pines retweeted
Thank you @mtlawton for inviting me to participate in this great symposium. Honored that our work @Brain_Circuits is one of the new frontiers in neurosciences @BarrowNeuro
Our Barrow Neurosciences Symposium: “New Frontiers,” is in full swing. Thanks to the over 250 visitors who have come to @BarrowNeuro for this annual event… @foxmdphd
2
17
2,050
Andrew Pines retweeted
What are the neural correlates of human behavior? Much research has approached versions of this question between individuals but not within individuals. Are results from these 2 approaches similar? No! In over 4000 individuals, the neural correlates of cognitive control diverged between vs. within individuals -- a case of non-ergodicity and Simpson’s paradox. We think that non-ergodicity may be an important principle in human neuroscience. [1/12]
4
54
1
221
12,886
Andrew Pines retweeted
What does the future of @Brain_Circuits look like? Honored to host our annual retreat, working alongside a brilliant team of psychiatrists, neurologists, neurosurgeons, radiologists, and neuroscientists. Together we'll find out.
4
33
2,002
We often treat functional connectivity as if it’s an established measure of TMS target engagement. I’m not so sure. Check out our new paper by Samantha Baldi in @npp_journal on rsfMRI data from a head-to-head TMS trial. free: rdcu.be/feIya full: lnkd.in/eSdthbSg
2
16
1
35
4,896
Andrew Pines retweeted
Check out our new paper in Stereotactic and Functional Neurosurgery (@NeuroKarger) on the safety of using #fMRI in patients with implanted peripheral nerve field stimulation devices for #trigeminal pain. We have also completed data collection for a randomized, double-blind trial evaluating the efficacy of these devices with fMRI, and the analysis is currently underway. Stay tuned! More exciting results coming soon... @mhodaie @ClementTChow @alexMRIresearch @cmiorio @CA1CA2CA3CA4 @BrendanSantyr @ASSFNeurosurg @UofTNeuroSurge @KBI_UHN karger.com/sfn/article/doi/1…
2
11
481
Andrew Pines retweeted
Congratulations @shansiddiqi and Joe Taylor @Brain_Circuits on their paper in @molpsychiatry demonstrating the translational power of LNM and brain circuit therapeutics. It has already changed clinical TMS practice @BrighamWomens @harvardmed.
Our latest in @molpsychiatry: In patients with anxiety+depression, targeting a novel “anxiosomatic” circuit in dmPFC outperforms standard dlPFC target for anxiety, and equally effective for depression. nature.com/articles/s41380-0…
13
43
5,476
Our latest in @molpsychiatry: In patients with anxiety+depression, targeting a novel “anxiosomatic” circuit in dmPFC outperforms standard dlPFC target for anxiety, and equally effective for depression. nature.com/articles/s41380-0…
4
37
1
106
12,719
Andrew Pines retweeted
Our view on the LNM critique is out in @NatureNeuro rdcu.be/faKgy In our view the critique exposes limitations in statistical inference for LNM maps rather than LNM methodology Null models could address some of the important concerns, strengthening LNM’s value 1/9
1
23
1
67
8,861
Andrew Pines retweeted
Thoughtful response by @AndrewZalesky @cashmachine15 arguing that LNM is valid if specificity testing is included. Note that specificity testing has been included in almost every prior LNM paper including the first paper by Boes et al. 2015.
Our view on the LNM critique is out in @NatureNeuro rdcu.be/faKgy In our view the critique exposes limitations in statistical inference for LNM maps rather than LNM methodology Null models could address some of the important concerns, strengthening LNM’s value 1/9
1
8
1
24
5,210
Andrew Pines retweeted
Bahners et al. identify a brain network linked to optimal therapeutic outcomes in pts with Parkinson’s disease receiving DBS. The network operates in the high beta frequency range and closely resembles treatment-responsive networks mapped with fMRI. shorturl.at/CrCuP
2
19
1
66
7,778
Andrew Pines retweeted
Does connectivity of a DBS site relate to beta oscillations and clinical response in Parkinson’s disease? New paper by @bahnebahners @Brain_Circuits says yes! “We identified a DBS response network that resembles the MRI network and operates in the high beta band.”
Bahners et al. identify a brain network linked to optimal therapeutic outcomes in pts with Parkinson’s disease receiving DBS. The network operates in the high beta frequency range and closely resembles treatment-responsive networks mapped with fMRI. shorturl.at/CrCuP
10
31
3,684